The Food and Drug Administration proposed a risk-based framework to enhance oversight of pharmacy compounding practices, according to an AHA News Now report. FDA Commissioner Margaret Hamburg, MD, ...
Strive Compounding Pharmacy sues Eli Lilly and Novo Nordisk over alleged GLP-1 weight loss drug competition limits. Read more ...
The FDA encourages health care providers to educate their patients about the risks associated with using compounded topical finasteride. Reports of adverse events associated with the use of compounded ...
When endocrinologist Dan Bessesen, MD, looked online and saw how easy it would be for him to purchase a weight loss drug from ...
Two people blinded in Washington, D.C., in 2005. Three dead in Virginia in 2006 and three more in Oregon the following year. Twenty-one dead polo horses in Florida in 2009. Earlier this year, 33 ...
The repeat problems at Houston-based Empower Pharmacy include inadequate quality testing and a failure to clean equipment.
In 2025, the U.S. Food and Drug Administration (FDA or the Agency) issued a surprising number of enforcement letters to ...
Houston-based Empower Pharmacy is one of two compounding pharmacies sued by the pharmaceutical giant Eli Lilly earlier this month for allegedly selling "knockoff" versions of its weight loss and ...
Empower Pharmacy markets itself as a well-meaning rival to Big Pharma — one that seeks to democratize medicine by making affordable, personalized drugs for patients who need them. As one of an ...
Glucagon-like peptide-1 agonists, a class of medications known as GLP-1s, have grown in popularity, initially for the treatment of type 2 diabetes and more recently for obesity and other labeled and ...
Shortages and big price tags have driven patients to unconventional sources of GLP-1 drugs In late 2022, pharmacist Joseph Lambson got an unusual call from a poison control specialist. He said, “Hey ...
By Maggie Fick and Mrinalika Roy Jan 12 (Reuters) - Novo Nordisk CEO Mike Doustdar said on Monday as many as 1.5 million ...